Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Meden

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
Zentralblatt Fur Gynakologie|January 1, 1992
[Results of postoperative radiotherapy with iridium-192 in patients with ovarian cancer]T Krauss, H Meden, W Rath, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1995
[Increased serum level of c-erbB-2-coded protein p105 in patients with pre-eclampsia]H Meden, S Mielke, W Wuttke, et al.
The Journal of Obstetrics and Gynaecology Research|April 1, 1997
Elevated serum levels of the c-erbB-2 encoded oncoprotein fragment in cases of pure preeclampsia and HELLP syndromeH Meden, S Mielke, W Wuttke, et al.
Human Reproduction (Oxford, England)|September 1, 2000
Semen granulocyte elastase: its relevance for the diagnosis and prognosis of silent genital tract inflammationB Zorn, I Virant-Klun, H Meden-Vrtovec
European Journal of Gynaecological Oncology|January 1, 1996
Improved control of nausea and emesis with a new bromazepam-containing ondansetron regimen in ovarian cancer patients receiving chemotherapy with carboplatin and cyclophosphamideH Meden, O Meissner, A Conrad, et al.
European Journal of Gynaecological Oncology|January 1, 1997
Does an immunoscintigraphy with OC 125 affect the prognosis of ovarian cancer?R G Osmers, T Rybicki, H Meden, et al.
Anti-Cancer Drugs|February 1, 1991
Endometrial stromal sarcoma of the uterusH Meden, D Meyer-Rath, A Schauer, et al.
Orvosi Hetilap|March 22, 1992
[Etiology, pathophysiology and clinical aspect of endometriosis]S Gardó, G Illei, H Meden-Vrtovec, et al.
Journal of Endocrinological Investigation|September 13, 2008
Testosterone-related shortening of QTc interval in women with polycystic ovary syndromeB Vrtovec, H Meden-Vrtovec, M Jensterle, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 25, 1998
Overexpression of the oncogene c-erbB-2 (HER2/neu) and response to chemotherapy in patients with ovarian cancerH Meden, D Marx, T Roegglen, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Zentralblatt Fur Gynakologie|January 1, 1992
[Results of postoperative radiotherapy with iridium-192 in patients with ovarian cancer]T Krauss, H Meden, W Rath, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1995
[Increased serum level of c-erbB-2-coded protein p105 in patients with pre-eclampsia]H Meden, S Mielke, W Wuttke, et al.
The Journal of Obstetrics and Gynaecology Research|April 1, 1997
Elevated serum levels of the c-erbB-2 encoded oncoprotein fragment in cases of pure preeclampsia and HELLP syndromeH Meden, S Mielke, W Wuttke, et al.
Human Reproduction (Oxford, England)|September 1, 2000
Semen granulocyte elastase: its relevance for the diagnosis and prognosis of silent genital tract inflammationB Zorn, I Virant-Klun, H Meden-Vrtovec
European Journal of Gynaecological Oncology|January 1, 1996
Improved control of nausea and emesis with a new bromazepam-containing ondansetron regimen in ovarian cancer patients receiving chemotherapy with carboplatin and cyclophosphamideH Meden, O Meissner, A Conrad, et al.
European Journal of Gynaecological Oncology|January 1, 1997
Does an immunoscintigraphy with OC 125 affect the prognosis of ovarian cancer?R G Osmers, T Rybicki, H Meden, et al.
Anti-Cancer Drugs|February 1, 1991
Endometrial stromal sarcoma of the uterusH Meden, D Meyer-Rath, A Schauer, et al.
Orvosi Hetilap|March 22, 1992
[Etiology, pathophysiology and clinical aspect of endometriosis]S Gardó, G Illei, H Meden-Vrtovec, et al.
Journal of Endocrinological Investigation|September 13, 2008
Testosterone-related shortening of QTc interval in women with polycystic ovary syndromeB Vrtovec, H Meden-Vrtovec, M Jensterle, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 25, 1998
Overexpression of the oncogene c-erbB-2 (HER2/neu) and response to chemotherapy in patients with ovarian cancerH Meden, D Marx, T Roegglen, et al.
Pageof 11